Malek David I
SEC Form 4 insider trading activity
Malek David I has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Malek David I is listed as Director at Braveheart Bio, Inc. Inside the rolling window, Malek David I reported 1 open-market purchase totaling $75K in BRVE and no open-market sales.
Companies traded
Other insiders at BRVE
Insider Buying
$75K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Malek David I made?
Malek David I has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Malek David I trade?
Malek David I has filed SEC Form 4 disclosures for 1 company, including BRVE.
When was Malek David I's most recent SEC Form 4 filing?
Malek David I's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Malek David I's total buy and sell value in the current window?
Inside the rolling retention window, Malek David I bought $75K and sold $0 based on SEC Form 4 filings.
What was Malek David I's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 4,166 BRVE shares on 2026-08-07, worth $75K, per SEC Form 4 filings.